Company

LigaChem Biosciences

As of the edition of 20 October 2026, LigaChem Biosciences runs 3 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active2
Stopped1
Total3

Where its trials are

  • Infections: 4 trials led
  • Lungs and airways: 3 trials led
  • Cancer: 1 trials led